[Influence of female sex on the respiratory manifestations of connective tissue disease].
Connective tissue diseases predominating in females include disseminated lupus erythematosus, antiphospholipid syndrome, primary pulmonary hypertension, Sjögren's syndrome, and rheumatoid arthritis. Pulmonary involvement is not uncommon and clinical expression may be modified by pregnancy. In addition, a certain number of drugs used for their treatment have an effect on fertility and pregnancy. We review here these different aspects and female-specific diagnostic and therapeutic features of connective tissue diseases.
Benveniste
O
O
Service de Médecine Interne, Groupe Hospitalier Pitié-Salpêtrière, Paris. olivier.benveniste@psl.ap-hop-paris.fr
Herson
S
S
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D016736:Antiphospholipid Syndrome / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology; D001172:Arthritis, Rheumatoid / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology; D005260:Female; D006801:Humans; D006976:Hypertension, Pulmonary / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology; D008171:Lung Diseases / Q000209:etiology*; D008180:Lupus Erythematosus, Systemic / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology; D011247:Pregnancy; D017678:Sex Distribution; D012737:Sex Factors; D012859:Sjogren's Syndrome / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology; D013256:Steroids; D016387:Women's Health
D000893:Anti-Inflammatory Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D013256:Steroids